C177H195N52O28+ — CID 158085972
N-(2-amino-5-nitrophenyl)cyclohexanecarboxamide;[cyclohexyl(hydroxy)methylidene]oxidanium;bis(2-cyclohexyl-6-nitro-1H-benzimidazole);4-nitrobenzene-1,2-diamine;3-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)cyclohexan-1-amine;1-[4-(6-nitro-1H-benzimidazol-2-yl)piperidin-1-yl]ethanone;bis(6-nitro-2-piperidin-4-yl-1H-benzimidazole);6-nitro-2-pyridin-3-yl-1H-benzimidazole;6-nitro-2-pyridin-4-yl-1H-benzimidazole;bis(2-piperidin-4-yl-3H-benzimidazol-5-amine) (PubChem CID 158085972) has the molecular formula C177H195N52O28+ and a molecular weight of 3498.84 g/mol. Its IUPAC name is N-(2-amino-5-nitrophenyl)cyclohexanecarboxamide;[cyclohexyl(hydroxy)methylidene]oxidanium;bis(2-cyclohexyl-6-nitro-1H-benzimidazole);4-nitrobenzene-1,2-diamine;3-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)cyclohexan-1-amine;1-[4-(6-nitro-1H-benzimidazol-2-yl)piperidin-1-yl]ethanone;bis(6-nitro-2-piperidin-4-yl-1H-benzimidazole);6-nitro-2-pyridin-3-yl-1H-benzimidazole;6-nitro-2-pyridin-4-yl-1H-benzimidazole;bis(2-piperidin-4-yl-3H-benzimidazol-5-amine).
| Compound Name | N-(2-amino-5-nitrophenyl)cyclohexanecarboxamide;[cyclohexyl(hydroxy)methylidene]oxidanium;bis(2-cyclohexyl-6-nitro-1H-benzimidazole);4-nitrobenzene-1,2-diamine;3-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)cyclohexan-1-amine;1-[4-(6-nitro-1H-benzimidazol-2-yl)piperidin-1-yl]ethanone;bis(6-nitro-2-piperidin-4-yl-1H-benzimidazole);6-nitro-2-pyridin-3-yl-1H-benzimidazole;6-nitro-2-pyridin-4-yl-1H-benzimidazole;bis(2-piperidin-4-yl-3H-benzimidazol-5-amine) |
|---|---|
| PubChem CID | 158085972 |
| Molecular Formula | C177H195N52O28+ |
| Molecular Weight | 3498.84 g/mol |
| Exact Mass | 3496.54 |
| IUPAC Name | N-(2-amino-5-nitrophenyl)cyclohexanecarboxamide;[cyclohexyl(hydroxy)methylidene]oxidanium;bis(2-cyclohexyl-6-nitro-1H-benzimidazole);4-nitrobenzene-1,2-diamine;3-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)cyclohexan-1-amine;1-[4-(6-nitro-1H-benzimidazol-2-yl)piperidin-1-yl]ethanone;bis(6-nitro-2-piperidin-4-yl-1H-benzimidazole);6-nitro-2-pyridin-3-yl-1H-benzimidazole;6-nitro-2-pyridin-4-yl-1H-benzimidazole;bis(2-piperidin-4-yl-3H-benzimidazol-5-amine) |
| SMILES | CC(=O)N1CCC(c2nc3ccc([N+](=O)[O-])cc3[nH]2)CC1.NC1CCC(c2nc3ccc([N+](=O)[O-])cc3[nH]2)CC1.Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1.Nc1ccc([N+](=O)[O-])cc1N.Nc1ccc([N+](=O)[O-])cc1NC(=O)C1CCCCC1.Nc1ccc2nc(C3CCNCC3)[nH]c2c1.Nc1ccc2nc(C3CCNCC3)[nH]c2c1.Nc1cccc(-c2nc3ccc([N+](=O)[O-])cc3[nH]2)c1.O=[N+]([O-])c1ccc2nc(-c3cccnc3)[nH]c2c1.O=[N+]([O-])c1ccc2nc(-c3ccncc3)[nH]c2c1.O=[N+]([O-])c1ccc2nc(C3CCCCC3)[nH]c2c1.O=[N+]([O-])c1ccc2nc(C3CCCCC3)[nH]c2c1.O=[N+]([O-])c1ccc2nc(C3CCNCC3)[nH]c2c1.O=[N+]([O-])c1ccc2nc(C3CCNCC3)[nH]c2c1.[H]/[O+]=C(\O)C1CCCCC1 |
| InChI | InChI=1S/C14H16N4O3.C13H16N4O2.2C13H10N4O2.C13H17N3O3.2C13H15N3O2.2C12H14N4O2.2C12H8N4O2.2C12H16N4.C7H12O2.C6H7N3O2/c1-9(19)17-6-4-10(5-7-17)14-15-12-3-2-11(18(20)21)8-13(12)16-14;2*14-9-3-1-8(2-4-9)13-15-11-6-5-10(17(18)19)7-12(11)16-13;14-9-3-1-2-8(6-9)13-15-11-5-4-10(17(18)19)7-12(11)16-13;14-11-7-6-10(16(18)19)8-12(11)15-13(17)9-4-2-1-3-5-9;2*17-16(18)10-6-7-11-12(8-10)15-13(14-11)9-4-2-1-3-5-9;3*17-16(18)9-1-2-10-11(7-9)15-12(14-10)8-3-5-13-6-4-8;17-16(18)9-3-4-10-11(6-9)15-12(14-10)8-2-1-5-13-7-8;2*13-9-1-2-10-11(7-9)16-12(15-10)8-3-5-14-6-4-8;8-7(9)6-4-2-1-3-5-6;7-5-2-1-4(9(10)11)3-6(5)8/h2-3,8,10H,4-7H2,1H3,(H,15,16);5-9H,1-4,14H2,(H,15,16);2*1-7H,14H2,(H,15,16);6-9H,1-5,14H2,(H,15,17);2*6-9H,1-5H2,(H,14,15);2*1-2,7-8,13H,3-6H2,(H,14,15);2*1-7H,(H,14,15);2*1-2,7-8,14H,3-6,13H2,(H,15,16);6H,1-5H2,(H,8,9);1-3H,7-8H2/p+1 |
| InChIKey | FNNBERDAAWFNMH-UHFFFAOYSA-O |
| XLogP | 34.38 |
| TPSA | 1234.94 Ų |
| H-Bond Donors | 26 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 257 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3498.84 |
| LogP ≤ 5 | 34.38 |
| H-Bond Donors ≤ 5 | 26 |
| H-Bond Acceptors ≤ 10 | 52 |